Literature DB >> 27124110

Assessment and treatment of pain in thalassemia.

Ashutosh Lal1.   

Abstract

Pain is a subjective symptom whose prevalence can be grossly underestimated. The high proportion of adults with thalassemia who experience chronic pain is evident from recent surveys. However, pain has not received enough attention in the overall management of thalassemia. The association of pain with the type and treatment of thalassemia or with its comorbidities is unclear. Abnormal spine imaging is seen in patients reporting pain, although the role of osteopenia has not been established. Pain becomes more frequent with age. The lower back is the most common site and can be particularly disabling and difficult to treat. Treatable causes, such as extramedullary masses or disc herniation or fractures, must be ruled out. Some adults experience increasing pain when the hemoglobin drops at the end of transfusion cycles. Interdisciplinary management of pain is necessary, while overreliance on medications can be counterproductive. The impact of chronic pain on the quality of life must be acknowledged. Physical therapy, psychological counseling, and vocational rehabilitation are vital to management. I recommend a proactive approach for prevention of pain by maintaining optimal bone density and an active lifestyle. I further propose that a universal tool be adopted to document and characterize pain at routine clinic visits.
© 2016 New York Academy of Sciences.

Entities:  

Keywords:  bone health; chronic pain; thalassemia

Mesh:

Year:  2016        PMID: 27124110      PMCID: PMC4870117          DOI: 10.1111/nyas.13061

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  29 in total

1.  Bone pain in thalassaemia: assessment of DEXA and MRI findings.

Authors:  M Angastiniotis; N Pavlides; K Aristidou; A Kanakas; M Yerakaris; E Eracleous; T Posporis
Journal:  J Pediatr Endocrinol Metab       Date:  1998       Impact factor: 1.634

Review 2.  Management of chronic pain.

Authors:  M A Ashburn; P S Staats
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

3.  Spinal cord compression in thalassemia. Report of 12 cases and recommendations for treatment.

Authors:  S Issaragrisil; A Piankigagum; P Wasi
Journal:  Arch Intern Med       Date:  1981-07

4.  Quality of life in patients with thalassemia intermedia compared to thalassemia major.

Authors:  Zahra Pakbaz; Marsha Treadwell; Robert Yamashita; Keith Quirolo; Drucilla Foote; Laura Quill; Titi Singer; Elliott P Vichinsky
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

5.  Growth failure and bony changes induced by deferoxamine.

Authors:  N F Olivieri; G Koren; J Harris; S Khattak; M H Freedman; D M Templeton; J D Bailey; B J Reilly
Journal:  Am J Pediatr Hematol Oncol       Date:  1992

Review 6.  Opioids in chronic non-cancer pain: systematic review of efficacy and safety.

Authors:  Eija Kalso; Jayne E Edwards; Andrew R Moore; Henry J McQuay
Journal:  Pain       Date:  2004-12       Impact factor: 6.961

7.  Incidence of scoliosis in beta-thalassemia and follow-up evaluation.

Authors:  P Korovessis; D Papanastasiou; M Tiniakou; N G Beratis
Journal:  Spine (Phila Pa 1976)       Date:  1996-08-01       Impact factor: 3.468

Review 8.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

9.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Authors:  Caterina Borgna-Pignatti; Simone Rugolotto; Piero De Stefano; Huaqing Zhao; Maria Domenica Cappellini; Giovanni Carlo Del Vecchio; Maria Antonietta Romeo; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Avital Cnaan
Journal:  Haematologica       Date:  2004-10       Impact factor: 9.941

10.  Deferoxamine-induced bone dysplasia in patients with thalassemia major.

Authors:  P W Brill; P Winchester; P J Giardina; S Cunningham-Rundles
Journal:  AJR Am J Roentgenol       Date:  1991-03       Impact factor: 3.959

View more
  3 in total

Review 1.  Impact of bone disease and pain in thalassemia.

Authors:  Antonio Piga
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience.

Authors:  Irene Gagliardi; Mariella Celico; Maria Rita Gamberini; Margherita Pontrelli; Monica Fortini; Aldo Carnevale; Nicola Napoli; Maria Chiara Zatelli; Maria Rosaria Ambrosio
Journal:  Calcif Tissue Int       Date:  2022-03-04       Impact factor: 4.000

3.  Pain in β-thalassemia major patients: an important yet neglected issue.

Authors:  Amir Emami Zeydi; Abbas Heydari; Hossein Karimi Moonaghi
Journal:  Korean J Pain       Date:  2018-01-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.